Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bio Green Med SolutionBGMS -3.41%46 Equity-to-Asset is 0.91 as of Jun. 2026, which is 11% above its 10-year median of 0.82. GuruFocus rates BGMS with a GF Score™ of 46/100 and a GF Value™ of $2.61 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 1,789 Construction companies, Bio Green Med Solution ranks better than 98.38% on this metric.
Bio Green Med Solution (NAS:BGMS) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Bio Green Med Solution Equity-to-Asset Related Terms
Bio Green Med Solution Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Bio Green Med Solution's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BGMS vs SILO, ALZN, ENVB: Equity-to-Asset Comparison
For the Building Products & Equipment subindustry, Bio Green Med Solution's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio Green Med Solution Equity-to-Asset vs Construction Industry
For the Construction industry and Industrials sector, Bio Green Med Solution's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Bio Green Med Solution's Equity-to-Asset falls into.
Bio Green Med Solution Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Bio Green Med Solution's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio Green Med Solution (BGMS) has a Equity-to-Asset of 0.91 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Bio Green Med Solution and its competitors. This is 11% above median its historical median of 0.82. According to the industry distribution chart, Bio Green Med Solution ranks #29 out of 1789 companies in the Construction industry, placing it in the top 1.6%.
Is Bio Green Med Solution's Equity-to-Asset too high?
Bio Green Med Solution's current Equity-to-Asset of 0.91 is 11% above median its 10-year median of 0.82. The Construction industry median Equity-to-Asset is 0.45. Bio Green Med Solution's value of 0.91 is 102.2% above this industry median. Based on the distribution chart, Bio Green Med Solution ranks #29 out of 1789 companies in the Construction industry, which is in the top quartile — a strong position relative to peers. Overall, Bio Green Med Solution has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bio Green Med Solution's Equity-to-Asset compare to SILO and ALZN?
According to the Construction industry distribution chart, Bio Green Med Solution ranks #29 out of 1789 companies for Equity-to-Asset. This places Bio Green Med Solution in the top 2% of its industry — outperforming the majority of peers. The industry median Equity-to-Asset is 0.45. Bio Green Med Solution's value of 0.91 is 102.2% above this benchmark. While the company's 10-year median is 0.82 vs. the industry median of 0.45, Bio Green Med Solution has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Construction company?
The median Equity-to-Asset among Construction companies is 0.45, based on 1,789 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bio Green Med Solution's current Equity-to-Asset of 0.91 is 102.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Bio Green Med Solution and its competitors. For the Construction industry, the median Equity-to-Asset is 0.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bio Green Med Solution's current Equity-to-Asset is 0.91, which is 11% above median its own 10-year median of 0.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio Green Med Solution stock overvalued right now?
Based on GuruFocus' analysis, Bio Green Med Solution (BGMS) is currently considered Possible Value Trap. The stock's GF Value™ is $2.61, compared to a current price of $0.86 — trading 67% below its estimated fair value. The current Equity-to-Asset is 0.91, which is 11% above median its 10-year median of 0.82 and 102.2% above the Construction industry median of 0.45. Bio Green Med Solution's overall GF Score™ is 46/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Bio Green Med Solution (BGMS), the current Equity-to-Asset is 0.91 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bio Green Med Solution (BGMS) Overvalued in 2026?
Based on GuruFocus' analysis, Bio Green Med Solution stock appears to be undervalued.
The current stock price of $0.86 is trading 67% below its estimated GF Value™ of $2.61.
GuruFocus considers Bio Green Med Solution to be Possible Value Trap.
Key valuation signals for BGMS:
Equity-to-Asset: 0.91 (11% above median its 10-year median of 0.82)
GF Value™: $2.61 vs. price of $0.86 (67% below fair value)
Industry Position: 102.2% above the Construction median (#29 of 1789)
No single metric tells the full story. See the BGMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bio Green Med Solution Inc is engaged in the supply and trading of protective and fire safety equipment. The company distributes products such as fire extinguishers, foam systems, fire-resistant doors, personal protective equipment, and safety apparel. It also provides fire safety systems, including sprinkler systems, fire alarm systems, valves, and CO2 systems. The company operates across commercial, industrial, healthcare, and residential sectors, with a focus on distribution and compliance with applicable safety standards.
46GF Score
Get the complete analysis for BGMS
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BGMS has been successfully added to your 
